These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 4156786)

  • 21. Caffeine ingestion by rats increases noradrenaline turnover and results in self-biting.
    Miñana MD; Grisolía S
    J Neurochem; 1986 Sep; 47(3):728-32. PubMed ID: 2874191
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Central dopamine neurons and sensory processing.
    Ungerstedt U; Ljungberg T
    J Psychiatr Res; 1974; 11():149-50. PubMed ID: 4461787
    [No Abstract]   [Full Text] [Related]  

  • 23. Discovery of the mesocortical dopaminergic system: some pharmacological and functional characteristics.
    Thierry AM; Tassin JP; Blanc G; Stinus L; Scatton B; Glowinski J
    Adv Biochem Psychopharmacol; 1977; 16():5-12. PubMed ID: 883554
    [No Abstract]   [Full Text] [Related]  

  • 24. Dopamine turnover in the corpus striatum and the lumbic system after treatment with neuroleptic and anti-acetylcholine drugs.
    Andén NE
    J Pharm Pharmacol; 1972 Nov; 24(11):905-6. PubMed ID: 4405656
    [No Abstract]   [Full Text] [Related]  

  • 25. Brain dopamine and behaviour. A critical analysis of the relationship between dopamine antagonism and therapeutic efficacy of neuroleptic drugs.
    Crow TJ; Gillbe C
    J Psychiatr Res; 1974; 11():163-72. PubMed ID: 4461788
    [No Abstract]   [Full Text] [Related]  

  • 26. Stereoselective features of catecholamine dispostion and their behavioral implications.
    Snyder SH
    J Psychiatr Res; 1974; 11():31-9. PubMed ID: 4461801
    [No Abstract]   [Full Text] [Related]  

  • 27. Does dopamine play a role in schizophrenia?
    Carlsson A
    Psychol Med; 1977 Nov; 7(4):583-97. PubMed ID: 22890
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Influence of sexual differentiation on striatal and limbic catecholamines.
    Leret ML; González MI; Tranque P; Fraile A
    Comp Biochem Physiol C Comp Pharmacol Toxicol; 1987; 86(2):299-303. PubMed ID: 2882921
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Changes of kinetic constant of striatal tyrosine hydroxylase elicited by neuroleptics that impair the function of dopamine receptors.
    Zivkovic B; Guidotti A
    Brain Res; 1974 Oct; 79(3):505-9. PubMed ID: 4153770
    [No Abstract]   [Full Text] [Related]  

  • 30. Effects of 6-hydroxydopamine lesions of the prefrontal cortex on tyrosine hydroxylase activity in mesolimbic and nigrostriatal dopamine systems.
    Rosin DL; Clark WA; Goldstein M; Roth RH; Deutch AY
    Neuroscience; 1992 Jun; 48(4):831-9. PubMed ID: 1352864
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antimuscarinic actions of neuroleptic drugs.
    Miller R; Hiley R
    Adv Neurol; 1975; 9():141-54. PubMed ID: 167564
    [No Abstract]   [Full Text] [Related]  

  • 32. Possible etiology of schizophrenia: progressive damage to the noradrenergic reward system by endogenous 6-hydroxydopamine.
    Stein L; Wise CD
    Res Publ Assoc Res Nerv Ment Dis; 1972; 50():298-314. PubMed ID: 5071537
    [No Abstract]   [Full Text] [Related]  

  • 33. [Cerebral catecholamines in experimental excessive emotional stress].
    Belova TI; Kvetnanskiĭ R
    Usp Fiziol Nauk; 1981; 12(2):67-90. PubMed ID: 6115522
    [No Abstract]   [Full Text] [Related]  

  • 34. Effects of neuroleptics on the nigroneostriatal and mesocortical dopaminergic systems.
    Glowinski J
    Res Publ Assoc Res Nerv Ment Dis; 1975; 54():233-46. PubMed ID: 769114
    [No Abstract]   [Full Text] [Related]  

  • 35. Effect of apomorphine and pimozide on synthesis and turnover of labelled catecholamines in mouse brain.
    Nybäck H; Schubert J; Sedvall G
    J Pharm Pharmacol; 1970 Aug; 22(8):622-4. PubMed ID: 4394540
    [No Abstract]   [Full Text] [Related]  

  • 36. Interaction of ergot drugs with central monoamine systems. Evidence for a high potential in the treatment of mental and neurological disorders.
    Fuxe K; Fredholm BB; Agnati LF; Ogren SO; Everitt BJ; Jonsson G; Gustafsson JA
    Pharmacology; 1978; 16 Suppl 1():99-134. PubMed ID: 643908
    [No Abstract]   [Full Text] [Related]  

  • 37. Brain catecholamine content and turnover in aging rats.
    Carfagna N; Trunzo F; Moretti A
    Exp Gerontol; 1985; 20(5):265-9. PubMed ID: 4092759
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dopamine release and direct dopamine receptor activation in the central nervous system by D-145, an amantadine derivative.
    Svensson TH
    Eur J Pharmacol; 1973 Sep; 23(3):232-8. PubMed ID: 4746740
    [No Abstract]   [Full Text] [Related]  

  • 39. Catecholamine metabolism (and the biochemical assessment of sympathetic activity).
    Kopin IJ
    Clin Endocrinol Metab; 1977 Nov; 6(3):525-49. PubMed ID: 22412
    [No Abstract]   [Full Text] [Related]  

  • 40. Differential effects of D- and L-amphetamine on behavior and on catecholamine disposition in dopamine and norepinephrine containing neurons of rat brain.
    Taylor KM; Snyder SH
    Brain Res; 1971 May; 28(2):295-309. PubMed ID: 5113521
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.